GNS REFS™ Causal Machine Learning Platform Featured in GEN (Genetic Engineering & Biotechnology News)
GNS Healthcare’s causal machine learning platform REFS (Reverse Engineering , Forward Simulation) turns healthcare data into actionable insights to guide precision medicine and scientific discovery. “We reverse engineer causal models from healthcare data,” explains Diane Wuest, Ph.D., associate director, precision medicine initiatives, GNS Healthcare. “Once these models are built, they can be forward simulated and queried […]
WSJ Pro Venture Capital Coverage of Horizon Investment in GNS Highlights Application of Precision Medicine to Population Health
Health insurers that have struggled to curb rates of chronic illnesses are turning for help to innovative data-analysis startups Read the complete story here.
Modern Healthcare Reports Horizon Investment in GNS, Notes Diverse Stakeholders Among GNS Investors
Another Blues plan has invested in a small Cambridge, Mass.-based company that uses big data and computer modeling to help clinicians and researchers target treatments to individuals. Read the full article here.
GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes
Published by the Journal of Diabetes Science and Technology, Discoveries Result From Computer Models Created From EHR Data and Causal Machine Learning Technology CAMBRIDGE, Mass. – Feb. 29, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new intervention […]
Health Data Management Spotlights GNS Medication Adherence Program With OmedaRx
Medication management has evolved from intuition-based treatments to population health, which emerged in the mid-1990s with a top-down, rules-based approach that treats individuals as hypotheticals, says Colin Hill, chairman and CEO of GNS Healthcare. But traditional methods to determine which patients to reach out to don’t target people who are at high risk of negative […]
CNBC’s Squawk Box Calls on GNS CEO Colin Hill to Understand Use of Big Data in Employee Wellness
Prompted by a Wall Street Journalarticle, CNBC’s Squawk Box Invited GNS CEO Colin Hill to explain the value of big data and machine learning-enabled employee wellness programs and to address concerns about privacy. Watch the segment here.
Wall Street Journal Article Highlights Role of Consumer Data in Employee Wellness Programs
Employee wellness firms and insurers are working with companies to mine data about the prescription drugs workers use, how they shop and even whether they vote, to predict their individual health needs and recommend treatments. Read the full article here.
GNS Use of Machine Learning to Match Health Interventions to Individuals Featured by STAT
Health insurers are scooping up huge quantities of personal information in a bid to figure out when you’re likely to get sick —and to design interventions to keep you healthy. Read the full story here.
GenomeWeb: GNS Healthcare Lands $10M Series C Financing
NEW YORK (GenomeWeb) — GNS Healthcare has completed a $10 million Series C financing round, led by new investors including Celgene, Alexandria Real Estate Equities, and Gi Global Health Fund. The new investors joined prior investors in the round, including Cambia Health Solutions, Heritage Provider Network, and Mitsui USA. The firm said it would use […]
Governor Baker Appointments GNS Healthcare’s Colin Hill to the Health Information and Analysis Oversight Council
BOSTON, Mass. – September 22, 2015 – Today, Governor Charlie Baker announced three appointments to the Health Information and Analysis Oversight Council charged with developing the Center for Health Information and Analysis’ (CHIA) research agenda and analytic priorities. “I’m pleased to appoint three of the brightest minds in healthcare, big data and financing to positions […]